FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 13399. Adulteration and misbranding of atropine sulphate tablets, nitroglycerin tablets, quinine sulphate tablets, acetphenetidin tablets, morphine diacetyl tablets, morphine sulphate tablets, strychnine nitrate tablets, and codeine sulphate tablets. U. S. v. Bowman, Mell & Co. (Inc.). Plea of nolo contendere. Fine, $250. ✖Remove constraint Titles: 13399. Adulteration and misbranding of atropine sulphate tablets, nitroglycerin tablets, quinine sulphate tablets, acetphenetidin tablets, morphine diacetyl tablets, morphine sulphate tablets, strychnine nitrate tablets, and codeine sulphate tablets. U. S. v. Bowman, Mell & Co. (Inc.). Plea of nolo contendere. Fine, $250. Defendants Bowman, Mell & Co. (Inc.) ✖Remove constraint Defendants: Bowman, Mell & Co. (Inc.)

Refine by:

  • 13399. Adulteration and misbranding of atropine sulphate tablets, nitroglycerin tablets, quinine sulphate tablets, acetphenetidin tablets, morphine diacetyl tablets, morphine sulphate tablets, strychnine nitrate tablets, and codeine sulphate tablets. U. S. v. Bowman, Mell & Co. (Inc.). Plea of nolo contendere. Fine, $250.1